The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma.
Phase of Trial: Phase III
Latest Information Update: 18 Mar 2016
At a glance
- Drugs Simvastatin (Primary) ; Corticosteroids
- Indications Asthma
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 15 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 23 Oct 2013 Planned end date changed from 1 Jun 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.